Reassessing CRWD Stock: CrowdStrike’s EPS Estimates and Market Sentiment Reassessing CRWD Stock: CrowdStrike’s EPS Estimates and Market Sentiment

Photo of author

By Ronald Tech

CrowdStrike Holdings, Inc. CRWD, a prominent figure in cybersecurity, has long been a beacon of success in the ever-evolving tech landscape. The company’s recent unveiling of its second-quarter fiscal 2025 earnings on August 28, 2024, however, has stirred unease among investors. Analysts have mitigated CrowdStrike’s earnings per share (EPS) estimates, and the company’s roadmap for the remaining fiscal journey paints a more arduous path. The burning question arises – Is it time for investors to part ways with CRWD stock?

CrowdStrike’s Sales Stagnation and Updated Projections

In its Q2 fiscal 2025 report, CrowdStrike showcased robust growth, with revenue swelling by 32% year-on-year to a sum of $963.9 million, alongside a 33% surge in subscription revenues. The annual recurring revenue (ARR) soared to $3.86 billion, marking a solid 32% ascent from the previous year. At first glance, these figures may dazzle, but they cloak a stark reality of deceleration in the company’s growth momentum.

Preceding fiscal year 2023, CrowdStrike consistently outshined, boasting over 50% annual revenue expansion, securing its status as a high-flying tech entity. However, the growth trajectory began dwindling post fiscal 2024, plummeting to the low-30s percentage bracket in the most recent quarter.

Further darkening the horizon was the July 19 IT outage impacting multiple devices hinged on Microsoft Corporation’s MSFT Windows operating system worldwide. This crisis, as per CrowdStrike’s chief financial officer, Burt Podbere, diverted resources and deferred deals exceeding $60 million, with many still hanging in the balance.

This debacle, coupled with challenges like extended sales cycles, steered CrowdStrike towards revising its revenue and EPS forecast for fiscal 2025. The management now envisions total revenues ranging from $3.89 billion to $3.90 billion, reflecting a 27% to 28% year-on-year growth margin. The non-GAAP net income per share is set to hover between $3.61 and $3.65, both metrics trailing previous expectations.

Consequently, these revised projections, intertwined with management’s cautious commentary on customer spending and elongated deal cycles, nudged analysts to downwardly adjust their EPS prognostications. Analyst sentiment veering southward often serves as an ominous signal for looming underperformance.

CRWD’s Lavish Valuation: Too Pricy Amidst Slowing Momentum

CrowdStrike shares cascaded post the July 19 turmoil, with the updated fiscal 2025 guidance intensifying investor qualms. CRWD stock has tumbled by 24.4% since July 19, trailing behind the Zacks Internet – Software industry’s rally of 3.5%. Moreover, it has lagged its elite counterparts, Palo Alto Networks, Inc. PANW and Fortinet, Inc. FTNT, which witnessed meteoric hikes of 32.2% and 6.9%, respectively, during the same tides.

See also  <!DOCTYPE html><html lang="en"><head> <meta charset="UTF-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <title>Defensive Dividend Stocks Offering Stability Amid Pre-Election Volatility</title></head><body><h2>Exploring Zoetis - A Defensive Dividend Stock</h2><p>As the U.S. presidential election fast approaches, investor anxieties are reaching a fever pitch like an orchestra building up to a crescendo. In such times of market tumult, seeking refuge in defensive dividend stocks can be akin to finding a sturdy lifeboat in a stormy sea.</p><h2>The Resilient Rise of Zoetis</h2><p>Among the entities that stand out in this defensive arena is Zoetis Inc., a stalwart player in the realm of animal health. With a legacy spanning over seven decades, Zoetis has become a beacon of stability in a sea of market fickleness, akin to a lighthouse guiding ships through rough waters.</p><h3>A Fortified Fortress</h3><p>Despite a YTD dip of 4%, Zoetis has clung tenaciously to its pillars of stability amidst the tumultuous market winds. The company's market cap looms large at around $85.1 billion, offering an anchor of steadfastness when the market tides turn rough.</p><h3>A Flourishing Haven</h3><p>Zoetis' five-year streak of consecutive dividend increases speaks volumes about its resilience. The company sails ahead, paying out a quarterly dividend of $0.432 per share with an annualized dividend of $1.73 per share.</p><h2>Visionary Leadership and Financial Prowess</h2><p>In August, Zoetis made waves as it surpassed all expectations with its second-quarter earnings. Like an eagle soaring high above the clouds, the company posted a revenue of $2.4 billion, signaling an 8% rise from the previous year—a testament to its unyielding spirit in the face of adversity.</p><h3>The Bright Horizon</h3><p>Guided by CEO Kristin Peck's steady hand, Zoetis raised its fiscal 2024 guidance with the confidence of a sure-footed mountaineer conquering new heights. The company anticipates revenue growth between $9.10 billion and $9.25 billion, paving the way for a brighter future.</p><h2>The Astounding Acclaim and Future Projections</h2><p>With a resounding consensus of "Strong Buy" ratings from analysts, Zoetis stands as a paragon of excellence in the eyes of the market. The price targets put forth a promising future, with a potential upside of 15.7% from current levels.</p><h2>Diving into Kenvue - A Shield Against Turbulence</h2><p>Turning our gaze to another bastion of stability, Kenvue Inc. emerges as a formidable contender in the landscape of consumer health, a shield repelling the arrows of uncertain market forces.</p><h3>The Sturdy Bulwark</h3><p>With a rich heritage dating back over a century, Kenvue boasts a diversified portfolio of trusted brands, standing strong with a market cap of $43.1 billion. The stock has surged 23% in the past three months, outshining broader market indices like a gleaming beacon in the night sky.</p><h3>Ensuring Growth and Stability</h3><p>Kenvue's recent dividend increase underscores its unwavering commitment to shareholders, offering $0.205 per share and a hearty 3.64% yield. This move aligns with the company's endeavor to drive sustainable growth and provide a steady hand amid market turmoil.</p></body></html><!DOCTYPE html><html lang="en"><head> <meta charset="UTF-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <title>Financial News: Unlocking the Performance of Kenvue and American Water Works</title></head><body> Unlocking the Performance of Kenvue and American Water Works

Performance Metrics Post-July 19

Image Source: Zacks Investment Research

Even post recent price descents, CrowdStrike is perched at a forward 12-month price-to-earnings (P/E) ratio of 59.37X, towering over the industry’s average of 31.93X. Equally astronomic is the forward 12-month price-to-sales (P/S) ratio, with CRWD trading at a multiple of 14.08X, well above the industry’s 2.51X metric.

Hyper-growth stocks such as CrowdStrike are commonly valued based on their future prospects, translating to inflated stock prices relative to current earnings and sales. While this valuation calculus holds under the sun of robust growth, as in the case of CrowdStrike, any hint of a slowdown necessitates a recalibration of the premium warranted. Given the company’s swaying stance on the road ahead, the sustainability of this premium valuation remains questionable.

On the cybersecurity battleground, peers like Palo Alto Networks and Fortinet are parading more attractive valuations and coherent growth trajectories. PANW and FTNT are presently pegged at forward 12-month P/S multiples of 12.02X and 9.17X, respectively. In the realm of forward 12-month P/E ratios, Palo Alto Networks lingers at a 54.30X multiple, while Fortinet stands at 36.07X.

Adding to the labyrinth of questions, CRWD shares have broached beneath their 50-day and 200-day moving averages – cardinal technical thresholds often signaling a bleak trajectory.

Analyzing Bearish Movement through Moving Averages

Image Source: Zacks Investment Research

Endgame: Shedding CRWD Stock

While CrowdStrike unarguably reins over the cybersecurity realm, the amalgamation of stifled growth, revised outlook, and bearish technical indicators portend deeper shadows for its stock in the foreseeable horizon. The lofty valuation, paired with the downgraded EPS estimates, raises a red flag on its current worth.

For risk-averse investors or those seeking steadier growth pastures, relinquishing CRWD stock now stands as a prudent move. While the long-term cybersecurity prospects hold fort, the immediate headwinds bearing down on this Zacks Rank #4 (Sell) constituent loom too large to disregard.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.